BREAKING
Why Is PLTR Stock Up Today? Technical Rebound Follows Brutal February Selloff 6 hours ago Palantir Technologies Inc. (PLTR) Surges 5.0% — Developing Story 6 hours ago Live Nation Entertainment, inc (LYV) Misses Q4 2025 Earnings Estimates — EPS $0.73 vs $1.49 Expected 6 hours ago GRAIL, Inc (GRAL) Tops Q4 2025 Earnings Estimates — EPS $-2.46 vs $-3.26 Expected 6 hours ago Sensata (ST) Beats Q4 EPS Estimates By 4.6% In Third Consecutive Quarter 6 hours ago Sensata Technologies Holding plc (ST) Tops Q4 2025 Earnings Estimates — EPS $0.89 vs $0.85 Expected 6 hours ago Vicor (VICR) Q4 EPS of $0.63 Crushes Estimates by 425%, Revenue Surges 27.8% 6 hours ago Vicor Corporation (VICR) Tops Q4 2025 Earnings Estimates — EPS $0.63 vs $0.12 Expected 6 hours ago Why RingCentral Stock Dropped Despite Beating Earnings Estimates by 5.2% 6 hours ago RingCentral, Inc (RNG) Tops Q4 2025 Earnings Estimates — EPS $1.13 vs $1.07 Expected 6 hours ago Why Is PLTR Stock Up Today? Technical Rebound Follows Brutal February Selloff 6 hours ago Palantir Technologies Inc. (PLTR) Surges 5.0% — Developing Story 6 hours ago Live Nation Entertainment, inc (LYV) Misses Q4 2025 Earnings Estimates — EPS $0.73 vs $1.49 Expected 6 hours ago GRAIL, Inc (GRAL) Tops Q4 2025 Earnings Estimates — EPS $-2.46 vs $-3.26 Expected 6 hours ago Sensata (ST) Beats Q4 EPS Estimates By 4.6% In Third Consecutive Quarter 6 hours ago Sensata Technologies Holding plc (ST) Tops Q4 2025 Earnings Estimates — EPS $0.89 vs $0.85 Expected 6 hours ago Vicor (VICR) Q4 EPS of $0.63 Crushes Estimates by 425%, Revenue Surges 27.8% 6 hours ago Vicor Corporation (VICR) Tops Q4 2025 Earnings Estimates — EPS $0.63 vs $0.12 Expected 6 hours ago Why RingCentral Stock Dropped Despite Beating Earnings Estimates by 5.2% 6 hours ago RingCentral, Inc (RNG) Tops Q4 2025 Earnings Estimates — EPS $1.13 vs $1.07 Expected 6 hours ago
MRK

Merck & Co, inc

$MRK NYSE Jul 29, 2021 BMO Q2 2021

Investor Toolbox

Listen to Call

Watch or listen to the earnings call recording.

Open Webcast

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

MRK Coverage

Event Merck & Co., Inc. (MRK) Merck and Mayo Clinic Announce New Research and Development Collaboration to Support AI-Enabled Drug Discovery and Precision Medicine Feb 18, 2026 Event Merck & Co., Inc. (MRK) KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Plus Paclitaxel ± Bevacizumab, Approved for Certain Adults with PD-L1+ (CPS ≥1) Platinum-Resistant Ovarian Carcinoma as Second or Third Line Treatment Feb 11, 2026 Event Merck & Co., Inc. (MRK) Q4 2025 Earnings Call Feb 10, 2026 Transcript Merck & Co., Inc. (MRK) Q4 2025 Earnings Call Transcript Feb 4, 2026 Transcript Merck & Co., Inc. (MRK) Q2 2025 Earnings Call Transcript Jan 22, 2026 Transcript Merck & Co., Inc. (MRK) Q3 2025 Earnings Call Transcript Jan 22, 2026 News Key highlights from Merck’s (MRK) Q3 2025 earnings results Oct 30, 2025 News Infographic: How Merck (MRK) performed in Q3 2024 Oct 31, 2024